Stocks
Novartis AGNVS
NYSEHealthcarePharmaceuticals$153.44-0.53%
A Swiss-based pharmaceutical manufacturer focused on patented medicines across areas such as oncology, cardiovascular disease, immunology, and neuroscience. The company generates the majority of its revenue from innovative branded drugs sold globally and maintains a large clinical development pipeli...
Market Cap: $296.6B52W Range: $97.72 – $170.46
Congressional Interest in Novartis AG (NVS)
13 members of Congress have disclosed 50 trades in Novartis AG (NVS), a Healthcare company. The buy/sell breakdown shows 21 purchases versus 29 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
50
Unique Politicians
13
Buys
21
Sells
29
Who in Congress Is Trading NVS?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2026-03-13 | Rohit Khanna | sell | $1K – $15K |
| 2026-03-13 | Rohit Khanna | buy | $1K – $15K |